An explainer on which weight loss medicines Novo Nordisk makes and its main product lineup, from the outlet's ongoing GLP-1 series.
Recap by typeshit. Full story at BusinessWorld Online.
The Illinois governor is speaking openly about his own GLP-1 use, saying he wants to end the stigma around the drugs. The post comes from a political fan page on Facebook.
Trell argues a toned lower body comes from lean muscle, crediting weekly strength training and recovery fuel rather than Ozempic or peptides.
The FDA cleared Awiqli as the first weekly insulin for kids 10 and up with type 2 diabetes, and a CagriSema subgroup showed 25% weight loss in women.
A rundown on the pill version of Wegovy, covering what form it comes in and its availability. Thin on details, so tap through for the specifics.
The firm expects third-quarter revenue of $22.62 billion, slightly above consensus, and raised its 2027 forecasts on stronger Zepbound demand.
The recall was issued because there's no assurance the vials are sterile. Anyone using compounded GLP-1s may want to check the details.
Loading…